Article Information
History
- July 10, 2022.
Article Versions
- You are currently viewing Version 1 of this article (July 10, 2022 - 11:30).
- Version 2 (January 4, 2023 - 01:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kevin O’Neill1,†,
- Nelofer Syed2,*,†,
- Timothy Crook2,†,
- Sudhir Dubey3,
- Mahadev Potharaju4,
- Sewanti Limaye5,
- Anantbhushan Ranade6,
- Giulio Anichini2,
- Darshana Patil7,
- Sudha S Murthy7,
- Dadasaheb Akolkar7,
- Pooja Fulmali7,
- Vineet Datta7,
- Sachin Apurwa7,
- Jinumary John7,
- Ajay Srinivasan7 and
- Rajan Datar7
- 1Department of Neurosurgery, Imperial College Healthcare NHS Trust, London, UK
- 2Department of Brain Sciences, John Fulcher Neuro-Oncology Laboratory, Burlington Danes Building, Hammersmith Hospital, Imperial College London, London, UK
- 3Institute of Neurosciences, Medanta-The Medicity, Gurugram, India
- 4Department of Radiation Oncology, Apollo Speciality Hospitals, Chennai, India
- 5Department of Medical Oncology, Sir HN Reliance Foundation Hospital and Research Centre, Mumbai, India
- 6Department of Medical Oncology, Avinash Cancer Clinic, Pune, India
- 7Department of Research and Innovations, Datar Cancer Genetics Private Limited, Nasik, India
- ↵*CORRESPONDING AUTHOR Dr. Nelofer Syed. E-mail: n.syed{at}imperial.ac.uk, Phone: +4402075945292
↵† These authors contributed equally to this work.